Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06580184 · ClinicalTrials.gov registry record · NA
Theoretically Informed Behavioral Intervention
A NA study, sponsored by Yale University.
- Not yet
- Registry status
- NA
- Development phase
- 164
- Enrollment target
NCT06580184 is a NA study that has not yet begun recruiting, run by Yale University. The registered enrollment target is 164 participants.
The verdict
NCT06580184, a NA study, has not yet begun recruiting, sponsored by Yale University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
Study Summary
The goal of this waitlist control clinical trial is to learn if the tailored LEARN 2 platform can prevent HIV-related comorbidities with shared risk factors in men ages 18 and older living with HIV. The main question\[s\] are: 1. Can the virtual environment improve quality of life among these participants? 2. Does the LEARN 2 platform effectively serve as prevention education for HIV comorbidity shared risk factors? Researchers will compare participants receiving the LEARN2 virtual environment intervention to those in a waitlist control group to see if the intervention leads to improvements in quality of life and reductions in risk factors. Participants will be asked to: 1. Engage with the virtual environment weekly. 2. Participate in virtual live health educator sessions. 3. Complete daily assessments of personal health behaviors through Ecological Momentary Assessment.
Interventions
- BEHAVIORAL LEARN 2 Platform
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2026-10 |
| Est. Completion | 2029-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06580184
The ClinicalTrials.gov registry entry for NCT06580184 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LEARN 2 Platform is the first listed.
NCT06580184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06580184 about?
NCT06580184 is a clinical study titled "Theoretically Informed Behavioral Intervention". The goal of this waitlist control clinical trial is to learn if the tailored LEARN 2 platform can prevent HIV-related comorbidities with shared risk factors in men ages 18 and older living with HIV. The main question\[s\] are: 1. Can the virtual environment improve quality of life among these parti...
What is the current status of trial NCT06580184?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 164 participants. The study started on 2026-10. Estimated completion is 2029-03-31.
What interventions are being tested in trial NCT06580184?
The interventions under investigation include: LEARN 2 Platform (BEHAVIORAL).
Who is sponsoring clinical trial NCT06580184?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.